SkyKnight to invest in infusion services provider Apex Infusion
- Apex has approximately 40 ambulatory infusion suite locations
- Moussie Haile serves as CEO and co-founder of Apex
- Apex was founded in 2006
SkyKnight Capital has agreed to invest in Apex Infusion, a Signal Hill, California-based infusion services provider. No financial terms were disclosed.
FFL Partners will also remain a minority investor in the company.
Apex has approximately 40 ambulatory infusion suite locations.
Moussie Haile serves as CEO and co-founder of Apex.
“We are excited to partner with Rick, Moussie and FFL to continue building Apex into the alternate site infusion partner of choice for patients, providers and payors,” said Don Wu, managing director at SkyKnight Capital. “Our investment approach is guided by a firm belief that industry leaders are built by exceptional management teams delivering uncommon value to their customers, employees, and society. We believe Apex possesses each of these attributes and are honored to support the Company in elevating the standard of infusion care.”
SkyKnight was advised by Guggenheim Securities, LLC, Holland & Knight LLP, Bass Berry & Sims PLC, and Morrison Foerster. Apex was advised by Raymond James, Willkie Farr & Gallagher LLP, and Polsinelli.
Apex was founded in 2006.
